nodes	percent_of_prediction	percent_of_DWPC	metapath
Amobarbital—CHRFAM7A—corpus luteum—polycystic ovary syndrome	0.199	0.237	CbGeAlD
Amobarbital—CHRNA7—corpus luteum—polycystic ovary syndrome	0.161	0.192	CbGeAlD
Amobarbital—CHRFAM7A—ovarian follicle—polycystic ovary syndrome	0.156	0.186	CbGeAlD
Amobarbital—CHRNA7—ovarian follicle—polycystic ovary syndrome	0.126	0.15	CbGeAlD
Amobarbital—GRIA2—embryo—polycystic ovary syndrome	0.0231	0.0276	CbGeAlD
Amobarbital—GABRA4—pituitary gland—polycystic ovary syndrome	0.013	0.0155	CbGeAlD
Amobarbital—GRIA2—endocrine gland—polycystic ovary syndrome	0.0119	0.0141	CbGeAlD
Amobarbital—CHRFAM7A—female gonad—polycystic ovary syndrome	0.0116	0.0139	CbGeAlD
Amobarbital—CHRNA7—uterus—polycystic ovary syndrome	0.0115	0.0137	CbGeAlD
Amobarbital—CYP2A6—adipose tissue—polycystic ovary syndrome	0.0112	0.0134	CbGeAlD
Amobarbital—CHRFAM7A—endocrine gland—polycystic ovary syndrome	0.0108	0.0129	CbGeAlD
Amobarbital—GRIK2—endocrine gland—polycystic ovary syndrome	0.0107	0.0128	CbGeAlD
Amobarbital—GABRA3—endocrine gland—polycystic ovary syndrome	0.0104	0.0123	CbGeAlD
Amobarbital—CHRNA7—adrenal gland—polycystic ovary syndrome	0.0101	0.012	CbGeAlD
Amobarbital—CHRNA4—adrenal gland—polycystic ovary syndrome	0.00994	0.0118	CbGeAlD
Amobarbital—GABRA2—adipose tissue—polycystic ovary syndrome	0.00991	0.0118	CbGeAlD
Amobarbital—CHRNA7—female gonad—polycystic ovary syndrome	0.00939	0.0112	CbGeAlD
Amobarbital—CYP2A6—vagina—polycystic ovary syndrome	0.00933	0.0111	CbGeAlD
Amobarbital—GABRA2—adrenal gland—polycystic ovary syndrome	0.00889	0.0106	CbGeAlD
Amobarbital—CHRNA7—endocrine gland—polycystic ovary syndrome	0.00873	0.0104	CbGeAlD
Amobarbital—CHRNA4—endocrine gland—polycystic ovary syndrome	0.00862	0.0103	CbGeAlD
Amobarbital—GRIK2—Activation of Ca-permeable Kainate Receptor—DLG4—polycystic ovary syndrome	0.00835	0.052	CbGpPWpGaD
Amobarbital—GABRA2—vagina—polycystic ovary syndrome	0.00824	0.00982	CbGeAlD
Amobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2D—polycystic ovary syndrome	0.00546	0.034	CbGpPWpGaD
Amobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—DLG4—polycystic ovary syndrome	0.00483	0.0301	CbGpPWpGaD
Amobarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—TH—polycystic ovary syndrome	0.00381	0.0237	CbGpPWpGaD
Amobarbital—GRIK2—Activation of Kainate Receptors upon glutamate binding—DLG4—polycystic ovary syndrome	0.00381	0.0237	CbGpPWpGaD
Amobarbital—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—CAMK2D—polycystic ovary syndrome	0.00347	0.0216	CbGpPWpGaD
Amobarbital—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—DLG4—polycystic ovary syndrome	0.00307	0.0191	CbGpPWpGaD
Amobarbital—CYP2A6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00279	0.0174	CbGpPWpGaD
Amobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2D—polycystic ovary syndrome	0.0027	0.0168	CbGpPWpGaD
Amobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—DLG4—polycystic ovary syndrome	0.00239	0.0149	CbGpPWpGaD
Amobarbital—CYP2A6—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00199	0.0124	CbGpPWpGaD
Amobarbital—GABRA6—Ion channel transport—TRPV6—polycystic ovary syndrome	0.00193	0.012	CbGpPWpGaD
Amobarbital—GABRA4—Ion channel transport—TRPV6—polycystic ovary syndrome	0.00191	0.0119	CbGpPWpGaD
Amobarbital—CYP2A6—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.00188	0.0117	CbGpPWpGaD
Amobarbital—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00182	0.0113	CbGpPWpGaD
Amobarbital—GABRA6—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00175	0.0109	CbGpPWpGaD
Amobarbital—GABRA4—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00173	0.0107	CbGpPWpGaD
Amobarbital—GABRA5—Ion channel transport—TRPV6—polycystic ovary syndrome	0.0017	0.0106	CbGpPWpGaD
Amobarbital—GABRA3—Ion channel transport—TRPV6—polycystic ovary syndrome	0.00167	0.0104	CbGpPWpGaD
Amobarbital—GABRA2—Ion channel transport—TRPV6—polycystic ovary syndrome	0.00164	0.0102	CbGpPWpGaD
Amobarbital—GABRA5—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00153	0.00955	CbGpPWpGaD
Amobarbital—CYP2A6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00152	0.00949	CbGpPWpGaD
Amobarbital—GABRA3—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00151	0.00938	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00148	0.00922	CbGpPWpGaD
Amobarbital—GABRA2—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00148	0.00921	CbGpPWpGaD
Amobarbital—CYP2A6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00147	0.00913	CbGpPWpGaD
Amobarbital—GABRA1—Ion channel transport—TRPV6—polycystic ovary syndrome	0.0014	0.00869	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00132	0.00824	CbGpPWpGaD
Amobarbital—GABRA1—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00126	0.00786	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00121	0.00751	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.0012	0.00749	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00117	0.00728	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00107	0.00665	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00106	0.00663	CbGpPWpGaD
Amobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00105	0.00656	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00101	0.0063	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000994	0.00619	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000993	0.00618	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000981	0.00611	CbGpPWpGaD
Amobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000979	0.0061	CbGpPWpGaD
Amobarbital—GABRA6—Orphan transporters—PLAT—polycystic ovary syndrome	0.000967	0.00602	CbGpPWpGaD
Amobarbital—GABRA4—Orphan transporters—PLAT—polycystic ovary syndrome	0.000955	0.00594	CbGpPWpGaD
Amobarbital—CYP2A6—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.000952	0.00593	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000944	0.00588	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00094	0.00585	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000932	0.0058	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000905	0.00563	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000894	0.00557	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000879	0.00547	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000867	0.0054	CbGpPWpGaD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000865	0.00539	CbGpPWpGaD
Amobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—polycystic ovary syndrome	0.000854	0.00532	CbGpPWpGaD
Amobarbital—GABRA5—Orphan transporters—PLAT—polycystic ovary syndrome	0.000848	0.00528	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000841	0.00524	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000836	0.00521	CbGpPWpGaD
Amobarbital—GABRA3—Orphan transporters—PLAT—polycystic ovary syndrome	0.000833	0.00519	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000831	0.00517	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000828	0.00516	CbGpPWpGaD
Amobarbital—GABRA2—Orphan transporters—PLAT—polycystic ovary syndrome	0.000818	0.0051	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000813	0.00506	CbGpPWpGaD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000805	0.00501	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.0008	0.00498	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000799	0.00498	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.000789	0.00491	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000785	0.00489	CbGpPWpGaD
Amobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000775	0.00483	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000766	0.00477	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000762	0.00474	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00076	0.00473	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000747	0.00465	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000744	0.00463	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000738	0.0046	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000737	0.00459	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000734	0.00457	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000725	0.00451	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000712	0.00443	CbGpPWpGaD
Amobarbital—GABRA1—Orphan transporters—PLAT—polycystic ovary syndrome	0.000698	0.00435	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000693	0.00432	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000682	0.00425	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000682	0.00424	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000676	0.00421	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—DLG4—polycystic ovary syndrome	0.000674	0.00419	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000673	0.00419	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000672	0.00419	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000664	0.00414	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000653	0.00406	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000652	0.00406	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000641	0.00399	CbGpPWpGaD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000637	0.00396	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000633	0.00394	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000632	0.00394	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00063	0.00392	CbGpPWpGaD
Amobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000625	0.00389	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000624	0.00389	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—DLG4—polycystic ovary syndrome	0.000613	0.00382	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000608	0.00379	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000607	0.00378	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000601	0.00374	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00059	0.00367	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000583	0.00363	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00058	0.00361	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00057	0.00355	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000565	0.00352	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000559	0.00348	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000555	0.00345	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000552	0.00344	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000551	0.00343	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000551	0.00343	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000545	0.00339	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000537	0.00334	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000535	0.00333	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000534	0.00332	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000524	0.00326	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000519	0.00323	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—DLG4—polycystic ovary syndrome	0.000515	0.00321	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000515	0.00321	CbGpPWpGaD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000513	0.0032	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—DLG4—polycystic ovary syndrome	0.0005	0.00311	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000491	0.00305	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000486	0.00302	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000485	0.00302	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000482	0.003	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000481	0.00299	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000478	0.00298	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000474	0.00295	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000473	0.00295	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000472	0.00294	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00046	0.00286	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000457	0.00284	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000439	0.00273	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—DLG4—polycystic ovary syndrome	0.000428	0.00267	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000427	0.00266	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000425	0.00265	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—DLG4—polycystic ovary syndrome	0.000423	0.00263	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000422	0.00263	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000417	0.0026	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00041	0.00255	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.00041	0.00255	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000404	0.00251	CbGpPWpGaD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000383	0.00238	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—DLG4—polycystic ovary syndrome	0.000376	0.00234	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—DLG4—polycystic ovary syndrome	0.000369	0.0023	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—DLG4—polycystic ovary syndrome	0.000363	0.00226	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00035	0.00218	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000341	0.00213	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000338	0.00211	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000325	0.00202	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000322	0.002	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	0.000309	0.00193	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000273	0.0017	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000265	0.00165	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000254	0.00158	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000251	0.00156	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NMNAT3—polycystic ovary syndrome	0.00024	0.00149	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000236	0.00147	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000233	0.00145	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000225	0.0014	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000223	0.00139	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000219	0.00137	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SUOX—polycystic ovary syndrome	0.000219	0.00137	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000219	0.00136	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000216	0.00134	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000215	0.00134	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000213	0.00133	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000207	0.00129	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000204	0.00127	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000203	0.00127	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—POMC—polycystic ovary syndrome	0.000203	0.00127	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.0002	0.00124	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000189	0.00118	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000186	0.00116	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000183	0.00114	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000183	0.00114	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000183	0.00114	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000181	0.00113	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000179	0.00111	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000173	0.00108	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TEAD2—polycystic ovary syndrome	0.000173	0.00108	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00017	0.00106	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000164	0.00102	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000159	0.00099	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000156	0.000972	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000156	0.00097	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000153	0.000955	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000145	0.000905	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000138	0.000858	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—STAR—polycystic ovary syndrome	0.000131	0.000818	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000131	0.000814	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HMMR—polycystic ovary syndrome	0.000117	0.000729	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000113	0.000706	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000112	0.000696	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—LHB—polycystic ovary syndrome	0.000102	0.000634	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HSD3B2—polycystic ovary syndrome	9.96e-05	0.00062	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AKR1C1—polycystic ovary syndrome	9.64e-05	0.000601	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SULT2A1—polycystic ovary syndrome	8.88e-05	0.000553	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—RRM2—polycystic ovary syndrome	8.6e-05	0.000535	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—YAP1—polycystic ovary syndrome	8.29e-05	0.000516	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NAMPT—polycystic ovary syndrome	7.96e-05	0.000496	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	7.86e-05	0.00049	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	7.42e-05	0.000462	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	7.31e-05	0.000455	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TH—polycystic ovary syndrome	6.32e-05	0.000394	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	6.15e-05	0.000383	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	5.78e-05	0.00036	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	5.16e-05	0.000321	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	4.92e-05	0.000306	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	4.66e-05	0.00029	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	4.35e-05	0.000271	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	3.52e-05	0.000219	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	3.48e-05	0.000216	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—INS—polycystic ovary syndrome	3.46e-05	0.000215	CbGpPWpGaD
